Market Cap
$34.8M
ONMD
OneMedNet Corp
$5.39 ▼ -2.00%
Prev close $5.50Market cap$34.8M
Insider Buying Cluster (2 insiders)High Impact Filing (8/10) Biotech & Drug Discovery
Snapshot
The big-picture read on ONMD right now — valuation, ownership and activity at a glance.
Cap Size
Nano Cap
Inst. Holders
16 funds
Inst. Value
$6.7M
Inst. Activity
2 buys / 1 sells
Insider Activity
$3.2M buy / $0.00 sell
Insider Net $
$3.2M
Social Sentiment
60° Warm
SEC Reports
5
Press Releases
2
Price chart 30d -8.3%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 other
OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution
OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution
Sep 10, 2026 Insider
Yu Jeffrey bought 142,857 shares
Chief Medical Officer @ $0.6300 ($90.0K)
Jul 30, 2026 Insider
Jul 24, 2026 SEC Kosasa Thomas bought 1,449,275 shares
Director @ $0.6900 ($1000.0K)
OneMedNet filed an 8-K setting September 18, 2026 as the date for its 2026 Annual Meeting, with an August 11 record date
8-K — Impact 2/10
Analysis based on filing metadata only — document content was unavailable. OneMedNet Corp (ONMD) filed an EFFECT notice
EFFECT — Impact 3/10
Jun 30, 2026 Inst.
BlackRock, Inc. — ADD
120,980 shares ($86.0K)
Jun 30, 2026 Inst.
PNC FINANCIAL SERVICES GROUP, — DOUBLED
103,332 shares ($73.5K)
Jun 23, 2026 Insider
Yu Jeffrey bought 158,730 shares
Chief Medical Officer @ $0.6300 ($100.0K)
Social media sentiment
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
60°
Warm
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
5 SEC filing reports analyzed · 3 bullish, 0 bearish, 0 mixed, 2 neutral · avg impact 5.0/10.Plus 2 press releases.
NEUTRAL8-K2/10
OneMedNet filed an 8-K setting September 18, 2026 as the date for its 2026 Annual Meeting, with an A
Jul 24, 2026
NEUTRALEFFECT3/10
Analysis based on filing metadata only — document content was unavailable. OneMedNet Corp (ONMD) fil
Jul 13, 2026
BULLISHCLUSTER6/10
Three insiders (CEO, CMO, and a Director) made open-market purchases totaling ~$210K over five days,
Jun 17, 2026
BULLISHCLUSTER6/10
CEO Aaron Green and director/10% owner Thomas Kosasa made open-market purchases totaling $121K over
Jun 16, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 30, 2026
other
OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution
OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution
Sep 29, 2026
trading_halt
Halt Resumed: ONMD — trading resumed after T3 (News and Resumption Times)
Halted 2026-09-28T23:50:00.000Z | Resumed 2026-09-29T13:00:00.000Z
Sep 28, 2026
trading_halt
Trading Halt: ONMD — T3 (News and Resumption Times)
OneMedNet Corp Class A Cmn | Market: NASDAQ | Code: T3 — News and Resumption Times
Sep 28, 2026
trading_halt
Trading Halt: ONMD — T1 (News Pending)
OneMedNet Corp Class A Cmn | Market: NASDAQ | Code: T1 — News Pending
Sep 25, 2026
other
OneMedNet Corporation Announces 1-for-10 Reverse Stock Split
OneMedNet Corporation Announces 1-for-10 Reverse Stock Split
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Current FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
Institutional ownership
Which big funds own ONMD (from quarterly 13F filings) and who is adding or trimming.
16 institutional holders with $6.7M total value (9,373,725 shares) as of 2026-Q2. Top holders: Savant, VANGUARD, GEODE. Net buying activity: 2 institutions added/increased vs 1 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| Savant Capital, LLC | 7,219,243 | $5.1M | 77.2% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,152,210 | $819.2K | 12.3% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 334,332 | $237.7K | 3.6% | DOUBLED +128.0% |
| VANGUARD FIDUCIARY TRUST CO | 137,706 | $97.9K | 1.5% | — |
| BlackRock, Inc. | 120,980 | $86.0K | 1.3% | ADD +72.6% |
| STATE STREET CORP | 116,700 | $83.0K | 1.2% | ADD +41.5% |
| PNC FINANCIAL SERVICES GROUP, INC. | 103,332 | $73.5K | 1.1% | DOUBLED +498.7% |
| NORTHERN TRUST CORP | 46,835 | $33.3K | 0.5% | TRIM -31.5% |
| CAPTRUST FINANCIAL ADVISORS | 32,600 | $23.2K | 0.3% | — |
| TORONTO DOMINION BANK | 23,599 | $16.8K | 0.3% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | ADD | 70,096 | 120,980 | +72.6% | $86.0K |
| PNC FINANCIAL SERVICES GROUP, INC. | DOUBLED | 17,260 | 103,332 | +498.7% | $73.5K |
| HRT FINANCIAL LP | TRIM | 44,080 | 15,628 | -64.5% | $11.00 |
| Focus Partners Wealth | DOUBLED | 10,000 | 20,000 | +100.0% | $17.0K |
| UBS Group AG | NEAR_EXIT | 113,735 | 16,235 | -85.7% | $13.8K |
| HRT FINANCIAL LP | ADD | 29,176 | 44,080 | +51.1% | $37.00 |
| VANGUARD GROUP INC | ADD | 982,239 | 1,301,306 | +32.5% | $1.4M |
| STATE STREET CORP | ADD | 82,500 | 116,700 | +41.5% | $128.4K |
| UBS Group AG | DOUBLED | 653 | 113,735 | +17317.3% | $125.1K |
| VANGUARD GROUP INC | ADD | 747,500 | 982,239 | +31.4% | $1.1M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
3 insiders, 13 transactions. Net $3.2M — $3.2M bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Yu Jeffrey | Chief Medical Officer | BUY | 142,857 | $0.6300 | $90.0K |
| Jul 30, 2026 | Kosasa Thomas | Director | BUY | 1,449,275 | $0.6900 | $1000.0K |
| Jun 23, 2026 | Yu Jeffrey | Chief Medical Officer | BUY | 158,730 | $0.6300 | $100.0K |
| Jun 23, 2026 | Green Aaron | Chief Executive Officer | BUY | 36,650 | $0.5733 | $21.0K |
| Jun 16, 2026 | Yu Jeffrey | Chief Medical Officer | BUY | 172,414 | $0.5800 | $100.0K |
| Jun 15, 2026 | Green Aaron | Chief Executive Officer | BUY | 18,702 | $0.5396 | $10.1K |
| Jun 12, 2026 | Kosasa Thomas | Director | BUY | 158,730 | $0.6300 | $100.0K |
| Jun 12, 2026 | Green Aaron | Chief Executive Officer | BUY | 36,920 | $0.5581 | $20.6K |
| May 18, 2026 | Kosasa Thomas | Director | BUY | 268,817 | $0.9300 | $250.0K |
| Apr 23, 2026 | Kosasa Thomas | Director | BUY | 280,898 | $0.8900 | $250.0K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for ONMD.
Shares short
922,431
Settlement Sep 15, 2026
Change vs prior
+5.2%
Semi-monthly cycle
Days to cover
4.7
At avg daily volume
Of shares outstanding
≈1.6%
Estimate — not % of float
| Halted | Code | Reason | Status |
|---|---|---|---|
| Sep 28, 2026 | T3 | Resumption Scheduled | Resumed |
| Sep 28, 2026 | T1 | News Pending | Not resumed |
All ONMD filing & press-release reports (7)
- 8-K reportJul 24, 2026
- EFFECT reportJul 13, 2026
- CLUSTER reportJun 17, 2026
- CLUSTER reportJun 16, 2026
- PRESS-RELEASE reportApr 6, 2026
- PRESS-RELEASE reportApr 1, 2026
- PRESS-RELEASE reportMar 18, 2026